Citadel Advisors LLC lowered its position in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) by 19.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,709 shares of the company’s stock after selling 2,574 shares during the quarter. Citadel Advisors LLC owned approximately 0.61% of Invesco Nasdaq Biotechnology ETF worth $230,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter worth approximately $888,000. Strategic Financial Concepts LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth approximately $1,699,000. Tower Research Capital LLC TRC raised its holdings in Invesco Nasdaq Biotechnology ETF by 148.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 28,061 shares of the company’s stock worth $604,000 after purchasing an additional 16,768 shares in the last quarter. Finally, Advisory Services Network LLC raised its holdings in Invesco Nasdaq Biotechnology ETF by 5.8% during the fourth quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock worth $1,154,000 after purchasing an additional 2,922 shares in the last quarter.
Invesco Nasdaq Biotechnology ETF Trading Up 1.6%
IBBQ stock opened at $21.25 on Friday. Invesco Nasdaq Biotechnology ETF has a twelve month low of $17.84 and a twelve month high of $24.84. The company’s 50 day moving average is $20.24 and its two-hundred day moving average is $21.56. The stock has a market cap of $38.46 million, a P/E ratio of 23.20 and a beta of 0.61.
Invesco Nasdaq Biotechnology ETF Cuts Dividend
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Read More
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- What is the MACD Indicator and How to Use it in Your Trading
- A Large Oil Supply Draw Could Mean Upside in These 3 Energy Names
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Stocks Getting Rare Double Upgrades From Analysts
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- This Banking Giant Just Got a $90 Price Target Upgrade
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.